Board of Trustees of Univ. of Illinois settles patent infringement dispute involving generic version of Prezista®
Client(s) Board of Trustees of the University of Illinois, The
Jones Day represented the Board of Trustees of the University of Illinois in consolidated patent infringement actions against Mylan Pharmaceuticals Inc., Lupin Ltd., Lupin Pharmaceuticals Inc., and Teva Pharmaceuticals USA, Inc., relating to the defendants' submission of Abbreviated New Drug Applications to the FDA seeking approval of generic versions of Prezista® (darunavir), a market-leading protease inhibitor. We worked closely with the United States, which co-owns the patent-in-suit, and with our licensee Janssen Products, L.P., which markets Prezista® (darunavir). The matters settled shortly before trial pursuant to an agreement whereby the USA and the University granted a license to defendants in exchange for a royalty based on sales of their generic products during the term of the licensed patents.
Janssen Products, L.P., et al. v. Lupin Limited, et al., Case No. 2-10-cv-05954 (D.N.J.) (Judge Walls)